<i id='8DD65A9F8C'><strike id='8DD65A9F8C'><tt id='8DD65A9F8C'><pre id='8DD65A9F8C'></pre></tt></strike></i> 
WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.
In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.
advertisement
“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTED Log In
Medical records are filled with copy 
Bankrupt Pear's prescription app helped MassHealth save money, data suggests 
BioMarin wins approval for gene therapy to treat hemophilia A 
Doctors on social media are being harassed and cyberbullied 
Hepatitis C has a cure — but many Americans still lack access to it 
Why Eli Lilly’s earnings didn’t quite live up to the hype 
United colonoscopy coverage change 'may cost lives,' doctors say 
STAT Boddities: What happens to the brain when we get scared? 
After affirmative action ruling, medical educators look to 'holistic review' 
People with substance use disorder deserve online privacy 
FDA approval of Sarepta Duchenne genetic therapy gives me hope 
Bernie Sanders gets little from pharma CEOs on drug prices
Trump demands the U.S. pay no more for drugs than other countries … again 
FDA weighs limits of animal data in assessing artificial wombs
BioMarin wins approval for gene therapy to treat hemophilia A 
